Keeping You Informed

The Community Oncology Alliance (COA) today filed its third amicus curiae brief in federal court supporting efforts to reform the 340B Drug Pricing Program through the adoption of transparent rebate models.

A crisis is looming over community oncology practices if neither Congress nor CMS addresses parts of the Inflation Reduction (IRA) that could starve practices of revenue needed to deliver high-cost cancer drugs to patients.

Many individuals receiving therapy to treat their cancer faced insurance red tape and administrative inefficiencies, resulting in time toxicities, emotional and financial strain, as well as inequities in access to care, according to research entitled ‘The Insurance Maze: How Cancer Patients Get Lost in the Red Tape of Utilization Management’, which was published in the 2025 Red Tape Report by CancerCare.

Be sure to tell your cancer treatment team about any symptoms you are experiencing so they can determine if supportive or palliative care is appropriate. I

In 2024, COA’s Patient Advocacy Network (CPAN) provided advocacy, education, and engagement opportunities in multiple ways.

In 2023, COA’s Patient Advocacy Network (CPAN) provided advocacy, education, and engagement opportunities in multiple ways.

While the new year is always filled with energy and enthusiasm, it is also important to reflect on the impact of our advocacy accomplishments in 2022.

A Note from the Director of Patient Advocacy & Education .....

Advocacy Chats – Educational Conversations on Cancer Policy and Advocacy .....

Upcoming Advocacy Chats – Educational Conversations on Cancer Advocacy and .....